Barrington Research Initiates Coverage On Orthofix Medical with Outperform Rating, Announces Price Target of $16

+1.91%

Orthofix International NV

OFIX

0.00

Barrington Research analyst Michael Petusky initiates coverage on Orthofix Medical (NASDAQ: OFIX) with a Outperform rating and announces Price Target of $16.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Why Integer Holdings (ITGR) Is Up 5.7% After Announcing a $200 Million Share Buyback Plan

Is Bausch + Lomb's Revenue Recovery Strengthening Its Investment Case After Last Year’s Recall (BLCO)?

Neogen (NEOG): Assessing Valuation Following Recent Share Price Gains

QuidelOrtho Corporation (NASDAQ:QDEL) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Dentsply Sirona (XRAY): Evaluating Valuation After CFO Exit, Impairment Charges, and Lowered Sales Outlook

Envista Holdings (NVST): Considering Valuation as Analyst Targets Outpace Recent Share Price Moves

A Fresh Look at Align Technology (ALGN) Valuation After Q3 Earnings and New Digital Innovations

A Look at National Vision Holdings (EYE) Valuation After Raised Guidance and Improved Earnings